Michele Bernasconi

2.8k total citations
50 papers, 2.2k citations indexed

About

Michele Bernasconi is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Michele Bernasconi has authored 50 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 15 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Michele Bernasconi's work include Viral-associated cancers and disorders (17 papers), Immune Cell Function and Interaction (12 papers) and Sarcoma Diagnosis and Treatment (10 papers). Michele Bernasconi is often cited by papers focused on Viral-associated cancers and disorders (17 papers), Immune Cell Function and Interaction (12 papers) and Sarcoma Diagnosis and Treatment (10 papers). Michele Bernasconi collaborates with scholars based in Switzerland, United States and Germany. Michele Bernasconi's co-authors include Erkki Ruoslahti, Beat W. Schäfer, Pirjo Laakkonen, Patricia Jaaks, David Nadal, Jason A. Hoffman, Kimmo Porkka, Christoph Berger, Andrew Remppis and William J. Fredericks and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Michele Bernasconi

46 papers receiving 2.1k citations

Peers

Countries citing papers authored by Michele Bernasconi

Since Specialization

Citations

This map shows the geographic impact of Michele Bernasconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Bernasconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Bernasconi more than expected).

Fields of papers citing papers by Michele Bernasconi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Bernasconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Bernasconi. The network helps show where Michele Bernasconi may publish in the future.

Co-authorship network of co-authors of Michele Bernasconi

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Bernasconi. A scholar is included among the top collaborators of Michele Bernasconi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Bernasconi. Michele Bernasconi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future 2024 ·Medicinal Research Reviews ·(unknown), Jochen Rößler, Michele Bernasconi	4
2	Abstract 4015: Improvement of CAR T cell potency against low-density targets like L1CAM and FGFR4 in rhabdomyosarcoma 2024 ·Cancer Research ·(unknown), (unknown), (unknown), Michele Bernasconi, Jochen Rößler	0
3	Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Anne‐Christine Uldry, Peter K. Bode, (unknown), Rita Sala, Manfred Heller, Jochen Rößler, Michele Bernasconi	10
4	Rapid liposomal formulation for nucleolin targeting to rhabdomyosarcoma cells 2023 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Simone Aleandri, Paola Luciani, Jochen Rößler, Michele Bernasconi	6
5	CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models 2023 ·Journal of Experimental & Clinical Cancer Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jochen Rößler, Michele Bernasconi	13
6	CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein–Barr virus genes 2021 ·Cancer Immunology Immunotherapy ·Semjon Sidorov, (unknown), (unknown), (unknown), (unknown), Tarik Azzi, (unknown), Christoph Berger, Michele Bernasconi, Felix Niggli, Yvonne Perner, (unknown), Werner Kempf, David Nadal, Simone Bürgler	3
7	The mannose 6-phosphate receptor targeted with porphyrin-based periodic mesoporous organosilica nanoparticles for rhabdomyosarcoma theranostics 2020 ·Biomaterials Science ·Morgane Daurat, Christophe Nguyen, (unknown), Vincent Sol, Vincent Chaleix, Clarence Charnay, Laurence Raehm, Khaled El Cheikh, Alain Morère, Michele Bernasconi, (unknown), Marcel Garcia, Frédérique Cunin, Jochen Roessler, Jean‐Olivier Durand, Magali Gary‐Bobo	13
8	The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion 2016 ·PLoS ONE ·Patricia Jaaks, Valentina D’Alessandro, (unknown), (unknown), (unknown), Beat W. Schäfer, Michele Bernasconi	18
9	Telomerase Activity Impacts on Epstein-Barr Virus Infection of AGS Cells 2015 ·PLoS ONE ·(unknown), (unknown), (unknown), Jaap M. Middeldorp, Henri‐Jacques Delecluse, Roberto F. Speck, Michele Bernasconi, David Nadal	3
10	Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models 2014 ·Journal of Controlled Release ·Zsofia Kovacs‐Balint, Beat Werner, Anahita Rassi, Jörn Oliver Sass, (unknown), Michele Bernasconi	97
11	Oropharyngeal Group A Streptococcal Colonization Disrupts Latent Epstein-Barr Virus Infection 2013 ·The Journal of Infectious Diseases ·Seigo Ueda, Satoshi Uchiyama, Tarik Azzi, Claudine Gysin, Christoph Berger, Michele Bernasconi, Yasuaki Harabuchi, Annelies S. Zinkernagel, David Nadal	18
12	Furin Targeted Drug Delivery for Treatment of Rhabdomyosarcoma in a Mouse Model 2010 ·PLoS ONE ·(unknown), Valentina D’Alessandro, Felix Niggli, Beat W. Schäfer, Michele Bernasconi	29
13	Plasma cell toll‐like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production 2009 ·Immunology ·Marcus Dorner, Simone Brandt, Marianne Tinguely, Franziska Zucol, Jean‐Pierre Bourquin, (unknown), Christoph Berger, Michele Bernasconi, Roberto F. Speck, David Nadal	90
14	Distinct Ex Vivo Susceptibility of B-Cell Subsets to Epstein-Barr Virus Infection According to Differentiation Status and Tissue Origin 2008 ·Journal of Virology ·Marcus Dorner, Franziska Zucol, Christoph Berger, Rahel Byland, Gregory T. Melroe, Michele Bernasconi, Roberto F. Speck, David Nadal	23
15	Identification of a rhabdomyosarcoma targeting peptide by phage display with sequence similarities to the tumour lymphatic‐homing peptide LyP‐1 2008 ·International Journal of Cancer ·Hendrik Witt, (unknown), Kristiina Iljin, Oliver Greiner, Felix Niggli, Beat W. Schäfer, Michele Bernasconi	22
16	Immune activation suppresses initiation of lytic Epstein-Barr virus infection 2007 ·Cellular Microbiology ·Kristin Ladell, Marcus Dorner, (unknown), Christoph Berger, Franziska Zucol, Michele Bernasconi, Felix Niggli, Roberto F. Speck, David Nadal	32
17	Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray 2006 ·Virology Journal ·Michele Bernasconi, Christoph Berger, Jürg A. Sigrist, Athos Bonanomi, Jens Sobek, Felix Niggli, David Nadal	29
18	Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis 2003 ·Cancer Cell ·Johanna A. Joyce, Pirjo Laakkonen, Michele Bernasconi, Gabriele Bergers, Erkki Ruoslahti, Douglas Hanahan	195
19	Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR 2000 ·Oncogene ·Christiane Margue, Michele Bernasconi, Frederic G. Barr, Beat W. Schäfer	85
20	Molecular cloning and characterization of a human PAX-7 cDNA expressed in normal and neoplastic myocytes 1994 ·Nucleic Acids Research ·Beat W. Schäfer, Thomas Czerny, Michele Bernasconi, (unknown), Meinrad Busslinger	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact